BrightFocus Foundation Issues RFP for New Alzheimer’s Research

  • Press Release
Published on:

Grants Will Include Support for Early-Career Scientists

Clarksburg, MD—BrightFocus Foundation, through its Alzheimer’s Disease Research program, today issued a request for proposals for promising research on Alzheimer’s and related dementias.

New grants are available for research that begins in 2020, with an application deadline of November 4, 2019.  BrightFocus is open to funding research topics related to understanding and/or intervening with biological mechanisms of Alzheimer’s disease and related dementias. The organization’s scientific portfolio includes support for innovative research ideas from scientists in the early stages of their careers.

BrightFocus funding has blazed new trails of discovery, including breakthroughs that have led to multiple Nobel Prizes. Its Alzheimer’s program is currently supporting over 90 scientific projects worldwide. “We encourage scientists from around the globe to bring us their most creative, most innovative ideas,” says Diane Bovenkamp, PhD, BrightFocus Vice President for Scientific Affairs.

Check here for more information about the BrightFocus Alzheimer’s grants, including how to apply, or visit

Snapshot of Awards

Full Proposal deadline: November 4, 2019, 5:00 PM EST

Amount: $100,000 per year

Award durations: Standard Awards can be up to 3 years. Fellowship Awards can be up to 2 years.

Eligibility: All scientists working at non-profit and government laboratories are eligible to apply for a Standard Award. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency).

About BrightFocus

BrightFocus Foundation is a premier source of private research funding to defeat Alzheimer’s, macular degeneration, and glaucoma. The organization currently manages a global portfolio of over 200 projects, a $40 million investment in the bold science that will find the cures for diseases of mind and sight. We share the latest research findings and best practices to empower families impacted by these diseases. Learn more at